Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
VPD-737 for Treatment of Chronic Pruritus
Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients
† Study has passed its completion date and status has not been verified in more than two years.